Results of a New Virtual Program for Patients Overdue for Diabetic Retinopathy Evaluation.

IF 2.6 3区医学 Q2 OPHTHALMOLOGY

Ophthalmology and Therapy Pub Date : 2025-06-01 Epub Date: 2025-04-19 DOI:10.1007/s40123-025-01136-9

Shannan G Moore, Daniel X Chen, Munish Sharma, Rudy Hedayi, Donald S Fong, Bobeck S Modjtahedi

{"title":"Results of a New Virtual Program for Patients Overdue for Diabetic Retinopathy Evaluation.","authors":"Shannan G Moore, Daniel X Chen, Munish Sharma, Rudy Hedayi, Donald S Fong, Bobeck S Modjtahedi","doi":"10.1007/s40123-025-01136-9","DOIUrl":null,"url":null,"abstract":"Introduction: Diabetic retinopathy (DR) is one of the leading causes of preventable blindness in adults. Teleophthalmology for DR screening is becoming more prevalent; however, most programs are focused on baseline screening rather than screening and monitoring patients with established higher degrees of retinopathy. This study evaluated the incidence of detected ocular disease in a new virtual care program focused on assessing patients with a known history of retinopathy who were overdue for follow-up.Methods: A retrospective cohort study was performed on Kaiser Permanente Southern California patients with a prior diagnosis of DR who were at least 1 year overdue for their retinopathy assessment. The new virtual care program consisted of a scheduled technician visit where vision, intraocular pressure, macular optical coherence tomography (OCT), and ultrawide-field retinal photographs were taken and then remotely interpreted by a centralized clinical reading center. Patients who had a detected abnormality on imaging were referred to the clinic for further evaluation and management.Results: There were 790 patients enrolled in the program with an abnormality detected in 34.6% of patients. Of patients with a detected abnormality, 87.2% attended the recommended follow-up evaluation in the clinic. Concern for proliferative diabetic retinopathy (PDR) was the most common abnormality detected on imaging (10.3% of eyes). Treatments were administered to 27.2% of eyes that attended clinic evaluation following an abnormal screening result.Conclusion: Expanded teleophthalmology pathways can help achieve timely DR evaluation and increase access to care especially in vulnerable and medically underserved communities.","PeriodicalId":19623,"journal":{"name":"Ophthalmology and Therapy","volume":"14 6","pages":"1271-1280"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069766/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmology and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40123-025-01136-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Diabetic retinopathy (DR) is one of the leading causes of preventable blindness in adults. Teleophthalmology for DR screening is becoming more prevalent; however, most programs are focused on baseline screening rather than screening and monitoring patients with established higher degrees of retinopathy. This study evaluated the incidence of detected ocular disease in a new virtual care program focused on assessing patients with a known history of retinopathy who were overdue for follow-up.

Methods: A retrospective cohort study was performed on Kaiser Permanente Southern California patients with a prior diagnosis of DR who were at least 1 year overdue for their retinopathy assessment. The new virtual care program consisted of a scheduled technician visit where vision, intraocular pressure, macular optical coherence tomography (OCT), and ultrawide-field retinal photographs were taken and then remotely interpreted by a centralized clinical reading center. Patients who had a detected abnormality on imaging were referred to the clinic for further evaluation and management.

Results: There were 790 patients enrolled in the program with an abnormality detected in 34.6% of patients. Of patients with a detected abnormality, 87.2% attended the recommended follow-up evaluation in the clinic. Concern for proliferative diabetic retinopathy (PDR) was the most common abnormality detected on imaging (10.3% of eyes). Treatments were administered to 27.2% of eyes that attended clinic evaluation following an abnormal screening result.

Conclusion: Expanded teleophthalmology pathways can help achieve timely DR evaluation and increase access to care especially in vulnerable and medically underserved communities.

查看原文本刊更多论文

糖尿病视网膜病变评估逾期患者新虚拟程序的结果。

导读：糖尿病视网膜病变（DR）是导致成人可预防性失明的主要原因之一。远距眼科筛查DR越来越普遍；然而，大多数项目都侧重于基线筛查，而不是筛查和监测已经确定的视网膜病变程度较高的患者。这项研究评估了在一个新的虚拟护理项目中检测到的眼部疾病的发生率，该项目重点评估了有视网膜病变病史的患者，这些患者逾期未进行随访。方法：一项回顾性队列研究对Kaiser Permanente南加州先前诊断为DR的患者进行了研究，这些患者的视网膜病变评估至少延迟了1年。新的虚拟护理项目包括一个预定的技术人员访问，在那里拍摄视力、眼压、黄斑光学相干断层扫描（OCT）和超宽视场视网膜照片，然后由一个集中的临床阅读中心远程解读。在影像学上发现异常的患者被转介到诊所进行进一步的评估和处理。结果：790例患者入组，34.6%的患者检测到异常。在检测到异常的患者中，87.2%的患者在诊所参加了推荐的随访评估。增殖性糖尿病视网膜病变（PDR）是最常见的影像学异常（10.3%的眼睛）。在筛查结果异常后参加临床评估的眼睛中，有27.2%接受了治疗。结论：扩大远程眼科路径有助于实现及时的DR评估，并增加医疗服务的可及性，特别是在弱势和医疗服务不足的社区。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmology and Therapy OPHTHALMOLOGY-

CiteScore

4.20

自引率

3.00%

发文量

157

审稿时长

6 weeks

期刊介绍： Aims and Scope Ophthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from preclinical, clinical (all phases), observational, real-world, and health outcomes research around the use of ophthalmological therapies, devices, and surgical techniques. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Ophthalmology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. Rapid Publication The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of ophthalmic therapies. Open Access All articles published by Ophthalmology and Therapy are open access. Personal Service The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. Digital Features and Plain Language Summaries Ophthalmology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’. For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/ Publication Fees Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5250/$6000/£4300. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. Peer Review Process Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria. At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor. Preprints We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website. Please follow the link for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550 Copyright Ophthalmology and Therapy''s content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0. Contact For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.